SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: blankmind who wrote (10429)7/3/1998 1:18:00 PM
From: Mkilloran  Read Replies (1) of 23519
 
blankmind.....the new plant can rampup to about 8 mill units a qtr...32 mill units a year...divide by 52 weeks = 600,000 units a week divide again by 6 (no of units in a script) = 100,000 scripts a week production at max capacity.

Look at USA demand pre-Viagra and post Viagra...Muse will have a lot of these countries prior to Viagra being introduced...and then will lose a percentage after Viagra is available.

With good marketing from Astra and Janssen...i'd expect to see some numbers like this....UK 5,000 week ,Spain 5,000, Mexico 10,000,Russia 10,000, S Korea 5,000 Japan 10,000 Italy 5,000 India 20,000 Germany 8,000 France 5,000 China 20,000 Canada 3,000
Brazil 10,000 Australia 3,000 Argentina 3,000
Africia, latin America, far east, etc 20,000

USA to recover to 10,000
That's after Viagra is marketed in these countries.....I'd expect the initial numbers to be higher before Viagra is available....

These numbers exceed the capacity of the new plant in NJ....therefore the need for the plant in Ireland....
And don't rule out future products from Vivus ...reference the 10k report for additional clinical trials and potential products.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext